Five Ways Berkeley Lab is in the Fight Against COVID-19

For the past several months, teams of scientists at the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have utilized our world-class research facilities to contribute to the national response to COVID-19, resulting in a wide range of promising research.

Scaling-Up Production of New Tests and Treatments for COVID-19

The Advanced Biofuels and Bioproducts Process Development Unit, or ABPDU, is helping two biotech companies ramp up production of potential COVID-19-fighting technologies so they can be ready to meet global demand. One is a highly accurate, easy-to-use testing platform that is much speedier than current diagnostic methods; and the other is a rapid approach for generating antibodies, which may have the potential to be an effective treatment for COVID-19 infections. Go here for more information on this research.

The COVID-19 research performed at the ABPDU is supported by Caspr Biotech and Swiftscale Biologics. ABPDU is funded by the Department of Energy’s Bioenergy Technologies Office (BETO).

See other ways Berkeley Lab scientists are helping to address some of the many scientific challenges posed by the pandemic.